BMJ Open,
Journal Year:
2024,
Volume and Issue:
14(8), P. e077420 - e077420
Published: Aug. 1, 2024
Introduction
Post-
or
long-COVID-19
conditions
manifest
with
a
spectrum
of
symptoms
reminiscent
pulmonary,
musculoskeletal,
psychological
and
neurological
disorders.
Individuals
post-
syndrome
often
present
myalgia,
pulmonary
problems
fatigue,
which
significantly
impact
their
daily
functioning.
Physiotherapy
interventions
are
an
accepted
medical
remedy
for
these
symptoms.
This
scoping
review
aims
to
outline
the
evidence
physiotherapy
documented
in
scientific
literature,
specifically
focusing
on
hands-on
therapy.
Methods
analysis
conforms
methodological
framework
established
by
Joanna
Briggs
Institute
(JBI).
The
procedure
drafting
involves
several
steps,
starting
defining
research
question
inclusion
exclusion
criteria.
Eligible
studies
those
analysing
treatment
parameters
direct
patient
interaction
patients.
Telemedicine
entirely
home-based
workouts
will
be
excluded
aligning
context
outpatient
Germany.
literature
search
conducted
PubMed,
EBSCO
research,
Scopus,
Web
Science,
Embase,
PEDRO,
Cochrane
WISO
databases
two
independent
researchers.
Screening,
data
extraction
critical
appraisal
performed
researchers
using
assessment
tools
provided
JBI.
Extracted
encompass
demographic
characteristics,
definitions
conditions,
descriptions
interventions,
outcome.
Subsequently,
findings
disseminated
through
article
conference
presentation.
Ethics
dissemination
Given
that
this
does
not
involve
human
participants,
ethical
committee
approval
is
deemed
unnecessary.
results
published
peer-reviewed
journals
presented
at
academic
physiotherapeutic
conferences.
International Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
155(8), P. 1409 - 1421
Published: June 5, 2024
A
significant
Omicron
wave
emerged
in
China
December
2022.
To
explore
the
duration
of
humoral
and
cellular
response
postinfection
efficacy
hybrid
immunity
preventing
reinfection
patients
with
lung
cancer,
a
total
447
were
included
longitudinal
study
after
from
March
2023
to
August
2023.
Humoral
responses
measured
at
pre-Omicron
wave,
3
months
7
postinfection.
The
detected
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
specific
antibodies
including
antibodies,
anti-receptor
binding
domain
(RBD)
IgG,
neutralizing
against
SARS-CoV-2
wild
type
(WT)
BA.4/5
variant.
T
cell
WT
variant
evaluated
101
by
ELISpot
results
showed
that
Omicron-infected
symptoms
mild,
while
fatigue
(30.2%),
shortness
breath
(34.0%)
persistent
cough
(23.6%)
long-lasting,
vaccines
fever
cancer
patients.
higher
full
or
booster
vaccinated
than
those
unvaccinated
(p
<
.05
for
all
four
antibodies),
enhanced
persisted
least
months.
was
peptides
(21.3
vs.
16.0
SFUs/10
Acta Biomedica Scientifica (East Siberian Biomedical Journal),
Journal Year:
2024,
Volume and Issue:
9(3), P. 222 - 229
Published: July 24, 2024
Background.
It
is
known
that
COVID-19
can
be
followed
by
a
shift
in
the
hemostatic
system
towards
hypercoagulation,
which
more
pronounced
presence
of
diabetes
mellitus
(DM).
Tuberculosis
process
often
accompanied
with
hypercoagulation
syndrome.
Of
great
interest
study
state
systems
patients
pulmonary
tuberculosis
(TB)
concomitant
DM
who
have
had
COVID-19.The
aim.
To
relationship
between
and
fibrinolysis
moderate
severe
mellitus.Methods.
32
TB
were
divided
into
two
groups.
Group
1
included
16
previously
(TB-DM-COVID).
2
did
not
(TB-DM).Results.
was
found
TB-DM-COVID
likely
to
develop
hypercoagulable
compared
TB-DM
patients.
This
evidenced
frequent
shortening
such
indicator
as
activated
partial
thromboplastin
time
(43.7
%
25.0
cases,
respectively;
χ2
=
7.22;
p
0.01),
an
increase
fibrinogen
levels
25.0%,
0.01)
D-dimer
18.7
%,
14.74;
0.0001).
These
changes
closely
associated
systemic
inflammatory
response,
strong
positive
correlations
C-reactive
protein
(r
0.420;
erythrocyte
sedimentation
rate
0.433;
patients.Conclusion.
In
after
COVID-19,
COV
ID-19,
development
inflammation
develops
often.
BMJ Open,
Journal Year:
2024,
Volume and Issue:
14(8), P. e077420 - e077420
Published: Aug. 1, 2024
Introduction
Post-
or
long-COVID-19
conditions
manifest
with
a
spectrum
of
symptoms
reminiscent
pulmonary,
musculoskeletal,
psychological
and
neurological
disorders.
Individuals
post-
syndrome
often
present
myalgia,
pulmonary
problems
fatigue,
which
significantly
impact
their
daily
functioning.
Physiotherapy
interventions
are
an
accepted
medical
remedy
for
these
symptoms.
This
scoping
review
aims
to
outline
the
evidence
physiotherapy
documented
in
scientific
literature,
specifically
focusing
on
hands-on
therapy.
Methods
analysis
conforms
methodological
framework
established
by
Joanna
Briggs
Institute
(JBI).
The
procedure
drafting
involves
several
steps,
starting
defining
research
question
inclusion
exclusion
criteria.
Eligible
studies
those
analysing
treatment
parameters
direct
patient
interaction
patients.
Telemedicine
entirely
home-based
workouts
will
be
excluded
aligning
context
outpatient
Germany.
literature
search
conducted
PubMed,
EBSCO
research,
Scopus,
Web
Science,
Embase,
PEDRO,
Cochrane
WISO
databases
two
independent
researchers.
Screening,
data
extraction
critical
appraisal
performed
researchers
using
assessment
tools
provided
JBI.
Extracted
encompass
demographic
characteristics,
definitions
conditions,
descriptions
interventions,
outcome.
Subsequently,
findings
disseminated
through
article
conference
presentation.
Ethics
dissemination
Given
that
this
does
not
involve
human
participants,
ethical
committee
approval
is
deemed
unnecessary.
results
published
peer-reviewed
journals
presented
at
academic
physiotherapeutic
conferences.
